Unleashing bi‑functionalFusion Proteins We are creating a new class of fusion proteins through our Agonist Redirected Checkpoint (ARC®) technology. Solving a fundamental structural limitation of other modalities, ARC molecules target and unlock the TNFr superfamily in a unique fashion while simultaneously blocking an immune checkpoint. ModularTechnology Both targets on our dual-sided ARC molecules can be […]
